DIGOXIN
Generic: DIGOXIN
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
DIGOXINActive Substance
1975-10-24Original Approval
DIGOXIN is FDA application ANDA083391, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2024-03-04
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake DrivCross Contamination with Other Products:(mycophenolate mofetil).
Class III2024-03-25
Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake DriFailed Impurities/Degradation Specifications
Top Reported Reactions
1
DYSPNOEA
5,634 reports
2
NAUSEA
4,389 reports
3
DIZZINESS
4,165 reports
4
FATIGUE
3,918 reports
5
ATRIAL FIBRILLATION
3,649 reports
6
DIARRHOEA
3,506 reports
7
ASTHENIA
3,153 reports
8
VOMITING
3,087 reports
9
DEATH
3,063 reports
10
HYPOTENSION
2,926 reports